117 related articles for article (PubMed ID: 10912538)
1. Daily but not pulse calcitriol therapy improves growth in experimental uremia.
Mehls O; Knöller N; Oh J; Wesch H; Wünsche B; Schmitt CP
Pediatr Nephrol; 2000 Jul; 14(7):658-63. PubMed ID: 10912538
[TBL] [Abstract][Full Text] [Related]
2. Intermittent administration of parathyroid hormone (1-37) improves growth and bone mineral density in uremic rats.
Schmitt CP; Hessing S; Oh J; Weber L; Ochlich P; Mehls O
Kidney Int; 2000 Apr; 57(4):1484-92. PubMed ID: 10760084
[TBL] [Abstract][Full Text] [Related]
3. Daily or intermittent calcitriol administration during growth hormone therapy in rats with renal failure and advanced secondary hyperparathyroidism.
Sanchez CP; He YZ
J Am Soc Nephrol; 2005 Apr; 16(4):929-38. PubMed ID: 15728789
[TBL] [Abstract][Full Text] [Related]
4. Growth promoting effects of growth hormone and IGF-I are additive in experimental uremia.
Kovács GT; Oh J; Kovács J; Tönshoff B; Hunziker EB; Zapf J; Mehls O
Kidney Int; 1996 May; 49(5):1413-21. PubMed ID: 8731108
[TBL] [Abstract][Full Text] [Related]
5. Hypercalciuria due to combined growth hormone and calcitriol therapy in uremia: effects of growth hormone on mineral homeostasis in 75% nephrectomized weanling rats.
Kainer G; Nakano M; Massie FS; Foreman JW; Chan JC
Pediatr Res; 1991 Dec; 30(6):528-33. PubMed ID: 1805148
[TBL] [Abstract][Full Text] [Related]
6. Calcitriol pulse therapy is not more effective than daily calcitriol therapy in controlling secondary hyperparathyroidism in children with chronic renal failure. European Study Group on Vitamin D in Children with Renal Failure.
Ardissino G; Schmitt CP; Testa S; Claris-Appiani A; Mehls O
Pediatr Nephrol; 2000 Jul; 14(7):664-8. PubMed ID: 10912539
[TBL] [Abstract][Full Text] [Related]
7. Changes in bone mineral density, growth velocity and renal function of prepubertal uremic children during growth hormone treatment.
Lanes R; Gunczler P; Orta N; Bosquez M; Scovino R; Dominguez L; Esaa S; Weisinger JR
Horm Res; 1996; 46(6):263-8. PubMed ID: 8982736
[TBL] [Abstract][Full Text] [Related]
8. Improvement of growth and food utilization by human recombinant growth hormone in uremia.
Mehls O; Ritz E; Hunziker EB; Eggli P; Heinrich U; Zapf J
Kidney Int; 1988 Jan; 33(1):45-52. PubMed ID: 3352160
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the effects of daily and intermittent-dose calcitriol on serum parathyroid hormone and ionized calcium concentrations in normal cats and cats with chronic renal failure.
Hostutler RA; DiBartola SP; Chew DJ; Nagode LA; Schenck PA; Rajala-Schultz PJ; Drost WT
J Vet Intern Med; 2006; 20(6):1307-13. PubMed ID: 17186842
[TBL] [Abstract][Full Text] [Related]
10. Physiological doses of calcium regulatory hormones do not normalize bone cells in uraemic rats.
Szabó A; Freesmeyer MG; Abendroth K; Stein G; Rosivall L; El-Shakmak A; Ritz E
Eur J Clin Invest; 1999 Jun; 29(6):529-35. PubMed ID: 10354215
[TBL] [Abstract][Full Text] [Related]
11. Failure of high doses of calcitriol and hypercalcaemia to induce apoptosis in hyperplastic parathyroid glands of azotaemic rats.
Jara A; González S; Felsenfeld AJ; Chacón C; Valdivieso A; Jalil R; Chuaqui B
Nephrol Dial Transplant; 2001 Mar; 16(3):506-12. PubMed ID: 11239023
[TBL] [Abstract][Full Text] [Related]
12. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
13. How dietary phosphate, renal failure and calcitriol administration affect the serum calcium-phosphate relationship in the rat.
Jara A; Chacón C; Felsenfeld AJ
Nephrol Dial Transplant; 2002 May; 17(5):765-71. PubMed ID: 11981061
[TBL] [Abstract][Full Text] [Related]
14. Comparison of peripheral bone and body axis skeleton in a rat model of mild-to-moderate renal failure in the presence of physiological serum levels of calcitropic hormones.
Freesmeyer MG; Abendroth K; Faldum A; Krauss C; Stein G
Bone; 2001 Sep; 29(3):258-64. PubMed ID: 11557370
[TBL] [Abstract][Full Text] [Related]
15. Clinical effect of intravenous calcitriol administration on secondary hyperparathyroidism. A double-blind study among 4 doses.
Koshikawa S; Akizawa T; Kurokawa K; Marumo F; Sakai O; Arakawa M; Morii H; Seino Y; Ogata E; Ohashi Y; Akiba T; Tsukamoto Y; Suzuki M
Nephron; 2002 Apr; 90(4):413-23. PubMed ID: 11961400
[TBL] [Abstract][Full Text] [Related]
16. Effects of new vitamin D analogues on parathyroid function in chronically uraemic rats with secondary hyperparathyroidism.
Hruby M; Ureña P; Mannstadt M; Schmitt F; Lacour B; Drüeke TB
Nephrol Dial Transplant; 1996 Sep; 11(9):1781-6. PubMed ID: 8918622
[TBL] [Abstract][Full Text] [Related]
17. A comparison between daily and thrice-weekly i.v. administration of 1,25-dihydroxy-22-oxavitamin D(3) regarding suppression of parathyroid hormone secretion and calcaemic action in uraemic rats.
Hirata M; Endo K; Ohkawa H; Kumaki K; Kubodera N; Slatopolsky E; Kurokawa K; Fukagawa M
Nephrol Dial Transplant; 2002; 17 Suppl 10():37-40. PubMed ID: 12386267
[TBL] [Abstract][Full Text] [Related]
18. Growth hormone action is blunted by acidosis in experimental uremia or acid load.
Maniar S; Kleinknecht C; Zhou X; Motel V; Yvert JP; Dechaux M
Clin Nephrol; 1996 Jul; 46(1):72-6. PubMed ID: 8832158
[TBL] [Abstract][Full Text] [Related]
19. Zinc nutritional status modifies renal osteodystrophy in uremic rats.
Kimmel PL; Langman CB; Bognar B; Faugere MC; Chawla LS; Watkins DW; Malluche HH
Clin Nephrol; 2001 Dec; 56(6):445-58. PubMed ID: 11770796
[TBL] [Abstract][Full Text] [Related]
20. Effects of thyroparathyroidectomy, exogenous calcium, and short-term calcitriol therapy on the growth plate in renal failure.
Sanchez CP; He YZ
J Am Soc Nephrol; 2003 Jan; 14(1):148-58. PubMed ID: 12506147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
